At the pulse of heart disease

We are pioneers in the discovery and development of non-coding RNA-based therapeutics designed to address the root causes of heart disease.

Download the Cardior Factsheet


Oligonucleotide Therapeutics Xchange
Jefferies Healthcare Conference 2023
CDR132L featured in Nature Biotechnology

Cardior's lead candidate CDR132L is featured in the article "Genetic medicines aim straight for the heart" by Corman Sheridan published in Nature Biotechnology on April 04, 2023.